NCT02245555View on ClinicalTrials.gov

Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

1,060

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

December 31, 2007

Conditions
Prostatic Hyperplasia
Interventions
DRUG

Tamsulosin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02245555 - Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter